Literature DB >> 17106753

[Benign paroxysmal positional vertigo with and without manifest positional nystagmus: an 18-month follow-up study of 70 patients].

E Anagnostou1, D Mandellos, A Patelarou, D Anastasopoulos.   

Abstract

BACKGROUND: In this follow-up study of approximately 18 months we assessed parameters of medical management in a sample of 70 patients suffering from benign paroxysmal positional vertigo.
METHODS: Apart from demographic data, we evaluated the time interval from the appearance of the first symptoms until a diagnostic positional manoeuvre was performed, the efficacy of liberatory manoeuvres, the prescription of medication, the use of technical diagnostic resources and the relapse rate.
RESULTS: None of the patients had received a diagnostic positioning test until then. Moreover, in one out of three cases a further unnecessary technical diagnostic procedure was carried out. There was a tendency for the right labyrinth to be more frequently affected, a fact that was statistically independent from age and sex, as well as from overall prognosis, which was characterized by a 15.6% recurrence rate. All patients with manifest positional nystagmus were successfully treated: 87.2% immediately after the repositioning manoeuvre and the rest within 10 days by self-performing Brandt-Daroff exercises. Our retrospective analysis revealed that, given a normal neuro-otological examination, a typical medical history without manifest positioning nystagmus leads safely to the correct diagnosis.
CONCLUSION: The delay between the onset of symptoms and the diagnosis of BPPV is very often unduly long. A focused medical history may be diagnostic even in the absence of nystagmus during the Dix-Hallpike manoeuvre.

Entities:  

Mesh:

Year:  2007        PMID: 17106753     DOI: 10.1007/s00106-006-1458-8

Source DB:  PubMed          Journal:  HNO        ISSN: 0017-6192            Impact factor:   1.284


  25 in total

1.  A modified Epley's procedure for self-treatment of benign paroxysmal positional vertigo.

Authors:  A Radtke; H Neuhauser; M von Brevern; T Lempert
Journal:  Neurology       Date:  1999-10-12       Impact factor: 9.910

2.  Positional vertigo: clinical and experimental observations.

Authors:  H F SCHUKNECHT
Journal:  Trans Am Acad Ophthalmol Otolaryngol       Date:  1962 May-Jun

3.  [Histomorphological study of experimentally induced canalolithiasis].

Authors:  M Sanchez-Hanke; B Tolsdorff; R Leuwer
Journal:  HNO       Date:  2005-06       Impact factor: 1.284

4.  Dix-Hallpike maneuver results are not influenced by the time of day of the test.

Authors:  Phillip D Kramer; David A Kleiman
Journal:  Acta Otolaryngol       Date:  2005-02       Impact factor: 1.494

5.  Canalith repositioning for benign paroxysmal positional vertigo.

Authors:  Judith White; Panos Savvides; Neil Cherian; John Oas
Journal:  Otol Neurotol       Date:  2005-07       Impact factor: 2.311

6.  [Medical management of patients with benign paroxysmal positional vertigo].

Authors:  M von Brevern; F Lezius; K Tiel-Wilk; T Lempert
Journal:  Nervenarzt       Date:  2002-06       Impact factor: 1.214

7.  Curing the BPPV with a liberatory maneuver.

Authors:  A Semont; G Freyss; E Vitte
Journal:  Adv Otorhinolaryngol       Date:  1988

8.  Cupulolithiasis.

Authors:  H F Schuknecht
Journal:  Arch Otolaryngol       Date:  1969-12

9.  Cervicogenic headache: electronystagmography, perception of verticality and posturography in patients before and after C2-blockade.

Authors:  M Dieterich; W Pöllmann; V Pfaffenrath
Journal:  Cephalalgia       Date:  1993-08       Impact factor: 6.292

10.  Short- and long-term outcomes of canalith repositioning for benign paroxysmal positional vertigo.

Authors:  R A Nunez; S P Cass; J M Furman
Journal:  Otolaryngol Head Neck Surg       Date:  2000-05       Impact factor: 3.497

View more
  1 in total

Review 1.  Benign paroxysmal positional vertigo without nystagmus: diagnosis and treatment.

Authors:  Gabriella Assumpção Alvarenga; Maria Alves Barbosa; Celmo Celeno Porto
Journal:  Braz J Otorhinolaryngol       Date:  2011 Nov-Dec
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.